Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04756401
Title Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Iowa-Wide Oncology Research Coalition NCORP WITHDRAWN Des Moines Iowa 50309 United States Details
Mayo Clinic in Rochester WITHDRAWN Rochester Minnesota 55905 United States Details
Coborn Cancer Center at Saint Cloud Hospital WITHDRAWN Saint Cloud Minnesota 56303 United States Details
Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601 United States Details
State University of New York Upstate Medical University RECRUITING Syracuse New York 13210 United States Details
Carolinas Medical Center/Levine Cancer Institute RECRUITING Charlotte North Carolina 28203 United States Details
Spartanburg Regional Medical Center NOT_YET_RECRUITING Forest City North Carolina 28043 United States Details
Guthrie Medical Group PC-Robert Packer Hospital WITHDRAWN Sayre Pennsylvania 18840 United States Details
Marshfield Clinic Cancer Center at Sacred Heart NOT_YET_RECRUITING Eau Claire Wisconsin 54701 United States Details
Aurora Cancer Care-Milwaukee West WITHDRAWN Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field